Ellagic Acid and Its Nanoparticles Mitigate Atherosclerosis by Elevating Low-Density Lipoprotein Receptor Levels Through Targeting of the Epidermal Growth Factor Receptor.

Saved in:
Bibliographic Details
Title: Ellagic Acid and Its Nanoparticles Mitigate Atherosclerosis by Elevating Low-Density Lipoprotein Receptor Levels Through Targeting of the Epidermal Growth Factor Receptor.
Authors: Li GT; College of Agronomy Chuxiong Normal University Chuxiong China., Wang LT; Faculty of Basic Medical Science Kunming Medical University Kunming China., Yin HL; Key Laboratory of Pu-Er Tea Science Ministry of Education (College of Science, Yunnan Agricultural University) Kunming China., Zhao SQ; College of Agronomy Chuxiong Normal University Chuxiong China., Sheng J; Key Laboratory of Pu-Er Tea Science Ministry of Education (College of Science, Yunnan Agricultural University) Kunming China., Huang YW; Key Laboratory of Pu-Er Tea Science Ministry of Education (College of Science, Yunnan Agricultural University) Kunming China.; Yunnan Plateau Characteristic Agricultural Industry Research Institute Kunming China., Wang XJ; College of Agronomy Chuxiong Normal University Chuxiong China.
Source: FASEB bioAdvances [FASEB Bioadv] 2025 Nov 07; Vol. 7 (11), pp. e70069. Date of Electronic Publication: 2025 Nov 07 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101733210 Publication Model: eCollection Cited Medium: Internet ISSN: 2573-9832 (Electronic) Linking ISSN: 25739832 NLM ISO Abbreviation: FASEB Bioadv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2573-9832
DOI:10.1096/fba.2025-00178